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M A J O R A R T I C L E
Klebsiella Infection in Patients
with Thalassemia
B. H. Y. Chung,1 S. Y. Ha,1 G. C. F. Chan,1 A. Chiang,1 T. L. Lee,1 H. K. Ho,1 C. Y. Lee,2 C. W. Luk,3 and Y. L. Lau1
1Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, University of Hong Kong, 2Department of Paediatrics, Caritas Medical
Center, and 3Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong, China
Klebsiella infection has previously been reported in a few patients with transfusion-dependent thalassemia.
The incidence and clinical spectrum of this infection in our cohort of patients were reviewed retrospectively.
Among 160 patients observed for 12 years, there were 15 episodes of Klebsiella infection that occurred in 12
patients (7.5%), resulting in an incidence of 0.78 infections per 100 patient-years. The clinical spectrum included
sinusitis (4 cases), intracranial infection (5 cases), septicemia (4 cases), and abscesses of the liver, lung, kidney,
and parotid gland (1 case each). Three patients had recurrent infections involving different sites, 2 (16%) died
of fulminant septicemia, and 3 (25%) had significant permanent neurological deficits. The antibiotic suscep-
tibility pattern for the isolates was similar to the pattern for isolates recovered in the community. With regard
to predisposing factors, iron overload and liver function derangement were found to be significant on univariate
analysis ( and , respectively) but insignificant on multivariate analysis. Klebsiella infectionPp .046 Pp .049
was a serious and frequently encountered complication in our patients with transfusion-dependent thalassemia,
resulting in high mortality and morbidity rates.
Thalassemia is the most common single-gene disorder
in the world. In Hong Kong, the rates of carriage of
a-thalassemia and b-thalassemia are 5% and 3.4%, re-
spectively [1]. The estimated number of children who
had b-thalassemia major in Hong Kong in 1996 was
287 [2]. With the implementation of different means
of treatment, including blood transfusion, administra-
tion of deferoxamine, and hematopoietic and cord
blood stem cell transplantation [2–5], the probability
of 20-year-survival for patients with thalassemia major
in Hong Kong has reached 90% [6], a figure compa-
rable to the rate in such Western countries as Italy [7].
Despite all of these treatment successes, infection has
remained an important cause of death. In Hong Kong,
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infection was the second leading cause of death among
patients not receiving hematopoietic/cord blood stem
cell transplants [6], and, globally, infection has been
associated with mortality rates of 12.8%–46% [8, 9].
The most well documented causative agent is Yersinia
enterocolitica. In a cohort of patients from North Amer-
ica [10], 8% of patients with thalassemia had Yersinia
infection, and the estimated incidence was 0.6 episodes
per 100 patient-years; iron overload appeared to be an
important risk factor for infection [10].
Klebsiella infection in patients with thalassemia has
been described in a few case reports [11–13]. None-
theless, limited data are available with regard to the
incidence of infection and spectrum of clinical presen-
tation. We performed a retrospective study of Klebsiella
infection involving a cohort of 160 patients with trans-
fusion-dependent thalassemia in Hong Kong during a
12-year period.
METHODS
In Hong Kong, the treatment of patients with thalas-
semia major is ambulatory based and is performed in
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a hospital setting; therefore, hospital records have noted most
adverse events associated with this group of patients. The case
records for patients with thalassemia at 3 different pediatric
units in Hong Kong (Queen Mary Hospital, Queen Elizabeth
Hospital, and Caritas Medical Center) were retrospectively re-
viewed. The cohort consisted of 160 patients, which represented
∼56% of all patients in Hong Kong with thalassemia major [2].
Patient-years of observation were determined by adding the
number of years of medical history available during the 12-
year period. Patient age at the time of presentation, presenting
features, diagnosis, treatment received, and outcomes of Kleb-
siella infection were reviewed. Possible predisposing factors,
such as severity of iron overload, history of splenectomy, history
of diabetes, and degree of liver derangement, were investigated
for the 66 patients observed at Queen Mary Hospital.
RESULTS
Incidence of infection and patient characteristics. During
the 12-year period of 1991–2002, 12 (7.5%) of 160 patients
developed a total of 15 episodes of Klebsiella infection. This
results in an incidence of 0.78 infections per 100 patient-years.
Of these 12 patients, 8 were male and 4 were female. All of
the patients were receiving regular blood transfusions at the
time of Klebsiella infection. On the basis of the serum level of
ferritin ( , pmol/L), all of the patientsmean SD 4952 3311
were found to have at least moderate iron overload. All but
one of the patients were receiving subcutaneously administered
deferoxamine at the time of diagnosis of infection. One patient
(patient 11) did not receive deferoxamine after he underwent
splenectomy because of poor compliance. Six patients under-
went splenectomy, and 3 of the 12 patients developed diabetes
mellitus as a complication of iron overload. One patient had
received 2 allogeneic human leukocyte antigen–matched bone
marrow transplants from a sibling donor, but the transplants
failed both times. After the second transplantation, the patient
developed posttransplantation marrow aplasia, which rendered
him pancytopenic.
Clinical presentation, treatment, and outcome. Patient
age at the time of presentation varied widely, from 9 to 22 years
(median , years). The site of infection wasage SD 15.9 4.2
also highly variable: the head and neck region, the CNS, or
intra-abdominal organs were sometimes involved, or the in-
fection sometimes presented as septicemia (table 1). Two pa-
tients had multiple episodes (2 episodes in one patient and 3
episodes in the other) of Klebsiella infection at different sites.
In addition to antibiotic treatment, surgical treatment was often
necessary (for 10 of 15 episodes), either for eradication of in-
fective material at the site of infection or for obtaining speci-
mens for microbiological testing. Recurrent Klebsiella infection
occurred in 2 patients in addition to the patient who had re-
ceived 2 bone marrow transplants. Two patients died of ful-
minant Klebsiella septicemia, and 3 patients with CNS infection
had residual neurological deficits.
Microbiological findings and antibiotic susceptibility. Of
the 15 infections, 7 were caused by Klebsiella pneumoniae, 1
was caused by Klebsiella pneumoniae ozaenae, and subspecies
identification was not performed for the remaining 7. All iso-
lates were resistant to ampicillin but susceptible to aminogly-
cosides. Second-generation cephalosporins and trimethoprim-
sulfamethoxazole (TMP-SMZ) were the second-best treatment
choices, because only 1 isolate was resistant to both of them.
This pattern of antibiotic susceptibility was similar to that of
the strains isolated from our local community [14]. The patient
who had undergone bone marrow transplantation (patient 8)
had recurrent Klebsiella septicemia and had received prolonged
courses of therapy with different antibiotics. Initially, the Kleb-
siella strains were susceptible to aminoglycosides, second-
generation cephalosporins, and TMP-SMZ. However, antibiotic
resistance gradually developed, and, finally, extended-spectrum
b-lactamase appeared, and the strains were susceptible only to
imipenem and gentamicin.
Risk factors for Klebsiella infection. Potential predispos-
ing factors for Klebsiella infection in patients with thalassemia
major were examined for the patients treated at Queen Mary
Hospital, the teaching hospital of the University of Hong Kong,
where a comprehensive electronic clinical database for patients
with thalassemia is kept. We examined the age and sex of our
patients, as well as the severity of iron overload (the highest
ferritin level noted during follow-up) and whether there was a
history of splenectomy, because these are important predis-
posing factors for infection in patients with thalassemia [15].
We also investigated whether the patients had diabetes mellitus
or liver derangement (as determined by aspartate aminotrans-
ferase level and hepatitis B and C status), to determine the
association between these factors and Klebsiella infection in
other patient groups [16–20]. Only an elevated ferritin level
( ) and liver derangement ( ) were found toPp .046 Pp .049
be marginally significant on univariate analysis. No statistically
significant factors could be identified by multivariate logistic
regression analysis.
DISCUSSION
The incidence of Klebsiella infection among patients with thal-
assemia major was 0.78 infections per 100 patient-years, and
7.5% of our patients were infected. As determined by a liter-
ature search, 5 other Chinese patients who had thalassemia and
Klebsiella infection have been reported (table 1). According to
a review by Wanachiwanawin [15], Klebsiella species were re-
sponsible for 25% of all severe infections in patients with thal-
assemia in Thailand. Other important causative organisms in-
Table 1. Data on Klebsiella infection in patients with transfusion-dependent thalassemia from the present study and from a literature review.
Patient,
case
Sex, age
in yearsa Presenting feature(s) Diagnosis
Culture
specimen Treatment Outcome Reference
1 F, 14 Fever, tender swelling over forehead Sinusitis, epidural abscess Surgical Craniotomy, drainage,
antral washout
Recovery PR
2
A M, 21 Right upper quadrant pain Liver abscess Surgical CT-guided aspiration Recovery PR
B 22 Left-side neck swelling Cervical abscess Surgical I&D Recovery PR
C 29 Headache Meningitis, septicemia Blood, CSF No surgery Death PR
3
A M, 19 Fever, parotid swelling Parotid abscess Blood No surgery Recovery PR
B 20 Headache, changed sensorium Brain abscess Surgical Craniotomy Residual headache PR
4 F, 9 Convulsion, vomiting Brain abscess Surgical Craniotomy Recovery PR
5 M, 16 Chronic nasal block Sinusitis Surgical Antral washout Recovery PR
6 M, 15.5 Right ear pain, right eye swelling Sinusitis Surgical Drainage Recovery PR
7 F, 12 Right parotid swelling with fever Parotitis Surgical I&D Recovery PR
8 M, 21 Fever and cough after BMT Recurrent septicemia, pneumonia Bloodb No surgery Persistent fever PR
9 M, 12 Fever, vomiting, meningism, impaired
sensorium
Subdural empyema Surgical Craniotomy Right-side hemiparesis,
epilepsy
PR
10 F, 18.5 Fever, cough Lung and renal abscess, septicemia Blood, sputum No surgery Recovery PR
11 M, 11.5 Fever, cough, shock Pneumonia, septicemia Blood, sputum No surgery Death PR
12 M, 15.5 Right ear pain and discharge, right eye
swelling, headache
Sinusitis, right-side ethmoiditis,
right orbital cellulitis, basal
ganglia/internal capsule infarct
Surgical External ethmoidectomy,
antral washout
Mild residual left-side
hemiparesis
PR
13 M, 19 Precordial heavy sensation, upper arm
and shoulder pain
Liver abscess Surgical Surgical drainage Recovery [11]
14 M, 22 Fever for 1 week, later progression to
change of consciousness, vomiting,
headache
2 Liver abscesses complicated by
right-side pleural effusion,
meningitis
Surgical USG-guided drainage Recovery [11]
15 M, 27 Fever, vomiting, confusion Meningitis with sepsis and DIC Blood No surgery Death [12]
16 M, 15 Fever, sore throat; later became comatose Meningitis Blood, CSF Craniotomy Death [12]
17 F, 14 Fever, decreased breath sounds, left-side
postauricular pain, left eye pain, blurred
vision
Left-side endogenous endophthal-
mitis, mastoiditis, pneumonia
Surgical Anterior chamber irriga-
tion, core vitrectomy,
intravitreal antibiotics,
dexamethasone
Decreased visual acuityc [13]
NOTE. BMT, bone marrow transplantation; DIC, disseminated intravascular coagulopathy; I&D, incision and drainage; PR, present report; USG, ultrasonography.
a Age at the time of presentation.
b Culture indicated extended-spectrum b-lactamase in strain.
c Patient could not count fingers at a distance of 20 cm.
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cluded Escherichia coli (26% of infections), Salmonella species
(15% of infections), and Streptococcus pneumoniae (13% of
infections).
Yersinia species, however, seem to be a less important cause
of infection among patients with thalassemia at our institutions.
Since 1991, only 1 of 66 patients observed at Queen Mary
Hospital had Yersinia infection in the form of cellulitis [21].
Li et al. [6] reviewed the mortality and morbidity patterns for
a cohort of 232 patients and found that, of 19 episodes of
severe infection, 6 were caused by Klebsiella species, whereas
only 3 were caused by Yersinia species. It is known that Yersinia
infection tends to occur in cold climates [22] and is relatively
rare in tropical areas. We believe that this is just one of the
reasons for the low rate of Yersinia infection in Hong Kong.
This is also evident in Thailand [15], where there is a 10%
incidence of Yersinia infection among patients with thalassemia
major who receive deferoxamine. Of interest, the reports that
we could find about Klebsiella infection in patients with thal-
assemia were all from Asia. Whether the paucity of reports of
Klebsiella infection from places like Mediterranean Europe,
where thalassemia is prevalent, is genuine or whether it is be-
cause of underreporting needs further investigation.
Another finding worth noting is the high rates of mortality
and morbidity associated with Klebsiella infection. Two patients
(17%) died, and 3 patients (25%) had permanent neurological
deficits. This high incidence of complications was not found
in the Yersinia series by Adamkiewicz et al. [10], but it was
observed in the previous case reports of Klebsiella infection
among patients with thalassemia [11–13], in which 2 patients
with meningitis died and 1 patient with endopthalmitis had
permanent visual damage.
An attempt was made to identify the risk factors for Klebsiella
infection in patients with thalassemia major. A high ferritin
level and deranged liver function were significant only on uni-
variate analysis. Iron overload was known to be a significant
risk factor for Yersinia infection in patients with thalassemia
major [10, 23]. In laboratory studies, iron was found to be
essential for the growth of several bacteria, including Klebsiella
species [24, 25]. With regard to liver derangement, it can be
caused by either iron overload or chronic viral hepatitis. In our
series, no patients had hepatitis B infection. Hepatitis C has
been shown to be associated with elevated serum alanine ami-
notransferase levels [26] and more-severe hepatic fibrosis [27].
However, no significant difference was observed in the hepatitis
C carrier status between persons who were infected with Kleb-
siella species and those who were not ( ). Furthermore,Pp .07
no single, independent, significant risk factor could be found
by multiple logistic regression analysis, which suggests that mul-
tiple interacting risk factors existed and contributed to Klebsiella
infection in our patients with thalassemia major. A larger pa-
tient sample would be necessary to improve the power of the
statistical analysis in a future study.
In summary, Klebsiella infection was found to be an im-
portant complication of thalassemia major in local Chinese
patients, both in terms of the incidence and the associated
mortality and morbidity rates. Given the poor outcome of in-
fection, prompt treatment (including a sensible choice of an-
tibiotics and early surgical intervention) should be initiated
whenever there is suspicion of Klebsiella infection. Future stud-
ies should be performed to address predisposing factors.
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